Biosimilar is an anti-VEGF therapy for retinal vascular disorders

J&J moving to settle 1,000 talc lawsuits for more than $100M: Bloomberg esagonowsky Tue, 10/06/2020 – 08:38

Oxford Biomedica earns U.K. nod for 4th manufacturing suite to boost COVID-19 production kblankenship Tue, 10/06/2020 – 09:06

Just days after buyout notice, AMAG faces FDA push to withdraw premature-birth med Makena kblankenship Tue, 10/06/2020 – […]

Amid White House feud, FDA raises vaccine rules that could nix a pre-election COVID shot esagonowsky Tue, 10/06/2020 […]

The hearts of professional athletes adapt to training in a number of ways, including by increasing the number […]

Dual-energy CT adds value to routine interpretation of emergency department imaging studies by increasing radiologists’ diagnostic confidence, leading […]

NHS trusts in England have reported various risks to the safety of patients linked to staffing shortages, lack […]

Many of the arguments made by Thornley and colleagues against taking an elimination approach to covid-19 are misleading […]

Two-drug regimen continues to offer non-inferior efficacy compared to a three-drug regimen